Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

NCT00250679 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

443

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Bronchitis
Emphysema

Interventions

DRUG: Arformoterol tartrate inhalation solution
DRUG: Arformoterol 25 ųg BID
DRUG: Formoterol 12 ųg BID
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.